(Q50691005)
Statements
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. (English)
1 reference
1 reference
Elizabeth R Sharlow
1 reference
Ramesh K Ramanathan
1 reference
D Lynn Kirkpatrick
1 reference
David Friedland
1 reference
Sylvan B Green
1 reference
H-H Sherry Chow
1 reference
Catherine A Cordova
1 reference
Steven P Stratton
1 reference
Amanda Baker
1 reference
Tomislav Dragovich
1 reference
1 April 2007
1 reference
13
1 reference
7
1 reference
2109-2114
1 reference